Facial Paralysis Clinical Trials

Find Facial Paralysis Clinical Trials Near You

The Efficacy of Intradermal Acupuncture for Ocular Surface Diseases After Intractable Facial Paralysis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to explore the clinical efficacy of intradermal acupuncture in the treatment of ocular surface diseases after Intractable Facial Paralysis, and to seek effective and convenient treatment for ocular surface diseases after intractable peripheral facial paralysis. The main question it aims to answer is : Will the intradermal acupuncture intervention effectively reduce the OSDI score ? The researchers compared the intradermal acupuncture with the placebo-needle to observe whether the intradermal acupuncture could better improve the symptoms.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• 1.Male or female patients aged 18-65 years.

• 2.Meets diagnostic criteria for intractable peripheral facial paralysis, with disease duration from 1 month to 1 year. FNGS 2.0 ≥15 points; ENoG shows the ratio of CMAP amplitude≤ 20%.

• 3.At least one subjective ocular symptom (dryness, foreign body sensation, burning, fatigue, redness, fluctuating vision) and OSDI scores between 30 and 80.

• 4.Voluntarily provides written informed consent and can comply with treatment and follow-up.

Locations
Other Locations
China
The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
RECRUITING
Hangzhou
Contact Information
Primary
Binyan Yu Binyan Yu
20103034@zcmu.edu.cn
13758271294
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2028-03-25
Participants
Target number of participants: 78
Treatments
Experimental: Intradermal Acupuncture group(IA group)
basic background treatment + IA treatment
Placebo_comparator: Sham Intradermal Acupuncture group(SIA group)
basic background treatment + SIA treatment
Related Therapeutic Areas
Sponsors
Leads: The First Affiliated Hospital of Zhejiang Chinese Medical University

This content was sourced from clinicaltrials.gov